A Prospective, Single Center, Randomized, Double-blind, Placebo Controlled Study in Two Phases to Evaluate the Safety and Efficacy of ATx201 as a Topical Antibiotic Agent
Phase of Trial: Phase I/II
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Niclosamide (Primary)
- Indications Atopic dermatitis; Bacterial skin diseases; Eczema
- Focus Adverse reactions; First in man
- Acronyms DECOLAD
- Sponsors AntibioTx
- 19 Mar 2018 Status changed from recruiting to completed.
- 17 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.
- 17 Jan 2018 Planned primary completion date changed from 1 Nov 2017 to 1 Feb 2018.